Another example supporting this concept comes from MLL-driven AML, in which high levels of the histone demethylase KDM5B revert the histone modification patterns and gene expression programs established by MLL during leukemogenesis, thereby extinguishing LCS potential [41]. This evidence concerns the gene KMT2A and acute myeloid leukemia.